Diaryl ethers as opioid receptor antagonist

A compound of the formula (I) wherein the variables X 1 to X 10 , R 1 to R 7 including R 3' , E, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	WILLIAM GLEN HOLLOWAY, KUMIKO TAKEUCHI, ELIZABETH MARIE THOMAS, JAMES EDWARD MATT JUNIOR, MILES GOODMAN SIEGEL, MARTA GARCIA DE LA TORRE, NURIA DIAZ BUEZO, DANA RAE SMITH, JAMES ERWIN FRITZ, CONCEPCION PEDREGAL-TERCERO, MARIA-JESUS BLANCO-PILLADO, STEVEN JAMES QUIMBY, RUSSELL DEAN STUCKY, CHAD NOLAN WOLFE, CHARLES HOWARD MITCH, MARK DONALD CHAPPELL
Format:	Patent
Sprache:	eng
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A compound of the formula (I) wherein the variables X 1 to X 10 , R 1 to R 7 including R 3' , E, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and Related Diseases is disclosed.